StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Operator: Good afternoon, and welcome to Oncolytics Biotech s Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript February 7, 2024 Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.0001, expectations were $-0.14. AVXL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. Welcome to […]
How Soon Might Anavex's Alzheimer's Drug Be Approved? The Good/Bad News (NASDAQ:AVXL) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.